Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

Sep 04

Cardiac Biotech

Cardiac Biotech

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

May 08

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.

CB Scientific, Inc. is now Cardiac Biotech Solutions, Inc., reflecting our mission to deliver advanced, cloud-connected cardiac monitoring technologies across global healthcare markets.

Feb 25

Cardiac Biotech

Cardiac Biotech

Officially Launches Next-Generation MyCardia AT Cardiac Monitor

CB Scientific, Inc. (CBSC) has officially launched its next-generation MyCardia AT cardiac event monitor in collaboration with Datrix, LLC. Designed for enhanced remote cardiac monitoring, the FDA-cleared device offers a lightweight, easy-to-use design with seamless integration into the MyCardia app ecosystem. The MyCardia AT monitor enables early detection of cardiac arrhythmias, helping physicians diagnose transient heart conditions more effectively. The device is set to roll out across SE Asia, Hong Kong, Macau, and pending regulatory approvals, Canada and China.

Oct 03

Cardiac Biotech

Cardiac Biotech

Trip Thomas Appointed as Chief Financial Officer

William "Trip" Thomas appointed Chief Financial Officer, succeeding Brooke Turk. Trip Thomas is a licensed CPA with extensive experience in financial reporting and regulatory compliance.

Aug 20

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market

CB Scientific, Inc. announces its voluntary delisting from the OTCQB Venture Market to preserve capital for future business growth. The company's common shares will continue trading on the OTC Pink Open Market.

Mar 19

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Concludes its Annual Meeting of Stockholders

Shareholders endorse name change to Cardiac Biotech Solutions, Inc. subject to regulatory approval

Mar 09

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement

Your Heart Protector Corp. to market the Company's products and provide associated monitoring services throughout Canada

Sep 06

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor

Updated product to include significant operating improvements and material design advances over the current offering

Aug 23

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. (CBSC) and Shenzhen Pump Medical Co., Ltd. Announce Cooperative Manufacturing Agreement for Chinese Market

Shenzhen Pump Medical Co. Ltd. to formally become the recognized manufacturer of record for CBSC's myCam device, cloud-based software, and smartphone app in China.

May 24

Cardiac Biotech

Cardiac Biotech

Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device

Enhanced product to include significant operating enhancements and material design advances over the current offering

How can we help you?

Contact Us

© 2020-2026. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.